- Home
- RLAY vs EDN Comparison
RLAY vs EDN Comparison
Compare RLAY & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- EDN
- Stock Information
- Founded
- RLAY 2015
- EDN 1992
- Country
- RLAY United States
- EDN Argentina
- Employees
- RLAY N/A
- EDN N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- EDN Electric Utilities: Central
- Sector
- RLAY Health Care
- EDN Utilities
- Exchange
- RLAY Nasdaq
- EDN Nasdaq
- Market Cap
- RLAY 803.4M
- EDN 675.2M
- IPO Year
- RLAY 2020
- EDN 2007
- Fundamental
- Price
- RLAY $5.48
- EDN $15.38
- Analyst Decision
- RLAY Strong Buy
- EDN
- Analyst Count
- RLAY 8
- EDN 0
- Target Price
- RLAY $17.25
- EDN N/A
- AVG Volume (30 Days)
- RLAY 1.6M
- EDN 202.3K
- Earning Date
- RLAY 11-05-2025
- EDN 08-11-2025
- Dividend Yield
- RLAY N/A
- EDN N/A
- EPS Growth
- RLAY N/A
- EDN N/A
- EPS
- RLAY N/A
- EDN 0.21
- Revenue
- RLAY $8,355,000.00
- EDN $1,911,272,136.00
- Revenue This Year
- RLAY $27.33
- EDN $37.74
- Revenue Next Year
- RLAY $8.87
- EDN $27.07
- P/E Ratio
- RLAY N/A
- EDN $4.06
- Revenue Growth
- RLAY N/A
- EDN 23.18
- 52 Week Low
- RLAY $1.78
- EDN $14.38
- 52 Week High
- RLAY $7.07
- EDN $51.69
- Technical
- Relative Strength Index (RSI)
- RLAY 75.63
- EDN 36.20
- Support Level
- RLAY $5.17
- EDN $14.38
- Resistance Level
- RLAY $5.42
- EDN $20.70
- Average True Range (ATR)
- RLAY 0.29
- EDN 1.33
- MACD
- RLAY 0.08
- EDN 0.10
- Stochastic Oscillator
- RLAY 95.97
- EDN 15.87
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.